DOCTOOLS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.7% 9.6% 10.5% 9.7% 15.7%  
Credit score (0-100)  31 24 23 24 12  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  460 1,015 288 220 30.9  
EBITDA  131 634 74.2 18.8 -24.6  
EBIT  131 634 74.2 18.8 -24.6  
Pre-tax profit (PTP)  126.2 648.2 68.8 17.0 -21.4  
Net earnings  98.4 505.6 53.6 13.2 -21.4  
Pre-tax profit without non-rec. items  126 648 68.8 17.0 -21.4  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  296 702 397 210 188  
Interest-bearing liabilities  17.9 169 147 150 88.4  
Balance sheet total (assets)  415 925 608 433 278  

Net Debt  -208 -448 -446 -273 -189  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  460 1,015 288 220 30.9  
Gross profit growth  28.9% 120.8% -71.6% -23.6% -86.0%  
Employees  1 0 0 0 1  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  415 925 608 433 278  
Balance sheet change%  3.1% 123.0% -34.3% -28.7% -35.8%  
Added value  130.5 634.1 74.2 18.8 -24.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 -1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  28.4% 62.5% 25.7% 8.5% -79.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  33.3% 97.6% 9.7% 3.8% -6.0%  
ROI %  43.7% 110.3% 10.5% 4.4% -6.7%  
ROE %  33.1% 101.3% 9.8% 4.4% -10.7%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  71.5% 75.9% 65.3% 48.4% 67.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -159.3% -70.7% -600.9% -1,454.9% 768.0%  
Gearing %  6.0% 24.1% 37.0% 71.7% 46.9%  
Net interest  0 0 0 0 0  
Financing costs %  69.2% 6.0% 3.5% 2.1% 0.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  3.5 4.1 2.9 1.9 3.1  
Current Ratio  3.5 4.1 2.9 1.9 3.1  
Cash and cash equivalent  225.9 617.2 592.4 423.6 277.5  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  296.4 701.9 396.6 209.8 188.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  131 0 0 0 -25  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  131 0 0 0 -25  
EBIT / employee  131 0 0 0 -25  
Net earnings / employee  98 0 0 0 -21